C LASSIFICATION of the Guillain-Barre syndrome has been the subject of much discussion and review (1-11). The diversity of the clinical manifestations has led some clinicians to establish criteria that would more precisely delimit the syn-drome (1). Others take issue with this re-strictive tendency, believing that it excludes certain clinical manifestations such as pro-found sensory loss, relapses, and ataxia that should be considered part of the syndrome (2-5, 12). This attempt at restrictive classi-fication of the syndrome would be securely based if the etiologic mechanism(s) were understood. Despite the widely accepted parainfectious etiologic component, it is
No takes yet. Share an insight, caveat, or question.
Robert C. Hinman (1967) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: